CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Activities
Net income	$ 339,255	$ 236,288	$ 99,229
Adjustments to reconcile net income to net cash provided by operating activities, net of effects of acquisitions:
Depreciation	112,149	106,219	91,747
Amortization of intangible assets	15,610	16,216	16,260
Amortization of debt issuance costs	950	754	1,455
Share-based compensation expense	36,287	33,205	25,260
Deferred income taxes	(39,225)	21,459	(14,456)
Investment loss (gain)	16,225	(37,896)	(1,766)
(Gain) loss on disposal of property, plant and equipment	(3,626)	243	119
Other	(4,016)	1,239	817
Changes in operating assets:
Change in accounts receivable	(20,163)	(52,721)	(10,501)
Change in inventory	(29,675)	(43,038)	(4,560)
Change in other operating assets	1,847	(25,445)	(9,067)
Changes in operating liabilities:
Change in accounts payable	(50,076)	55,628	7,422
Change in accrued liabilities	31,760	29,352	(9,198)
Change in income tax payable	(8,333)	(1,455)	(2,182)
Change in other operating liabilities	(6,468)	(1,505)	(3,359)
Net cash flows provided by operating activities	392,501	338,543	187,220
Cash flows from investing activities
Acquisitions, net of cash received	(83,979)	(157)	(24,593)
Disposal of wafer fabrication facility	19,270	9,939	0
Receipt of cash for termination of cross currency swap	9,429	0	0
Receipt of insurance recovery	6,067	0	0
Purchases of property, plant and equipment	(211,728)	(141,195)	(75,813)
Proceeds from sales of property, plant and equipment	418	3,207	232
Sales of short-term investments	8,002	7,328	10,277
Purchases of short-term investments	(9,361)	(7,567)	(11,486)
Purchase of equity securities	(4,051)	(15,106)	(6,131)
Other	670	(678)	742
Net cash and cash equivalents used by investing activities	(265,263)	(144,229)	(106,772)
Cash flows from financing activities
Advances on lines of credit and short-term debt	114,291	21,862	77,483
Repayments on lines of credit and short-term debt	(93,498)	(146,372)	(40,498)
Proceeds from long-term debt	372,751	557,882	956,363
Repayments of long-term debt	(505,746)	(586,001)	(744,237)
Debt issuance costs	(134)	(673)	(2,477)
Net proceeds from the issuance of common stock	140	4,337	6,830
Repayment of and proceeds from finance lease obligation	(69)	(291)	(919)
Taxes related to net share settlement	(12,300)	(14,823)	(8,302)
Net changes in noncontrolling interests	(1,160)	5,631	(2,102)
Repurchase of common stock	0	0	(296,705)
Other	12	7	262
Net cash and cash equivalents used in financing activities	(125,713)	(158,441)	(54,302)
Effect of exchange rate changes on cash and cash equivalents	(27,244)	10,416	34,876
Change in cash and cash equivalents, including restricted cash	(25,719)	46,289	61,022
Cash and cash equivalents, beginning of period, including restricted cash	366,818	320,529	259,507
Cash and cash equivalents, end of period, including restricted cash	341,099	366,818	320,529
Supplemental Cash Flow Information
Interest paid during the period	7,355	6,944	10,219
Taxes paid during the period	88,687	56,077	47,891
Non-cash investing and financing activities:
Accounts payable balance related to the purchase of property, plant and equipment	$ 30,486	$ 24,256	$ 7,297